Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 11, 2010 David Meier	Would Jeremy Grantham Buy Copart? The seasoned pro thinks high-quality companies are on sale. Let's find the bargains.
The Motley Fool August 11, 2010 David Meier	Would Jeremy Grantham Buy ADTRAN? The company currently earns a return on invested capital that is higher than its cost of capital. Fools love companies that take shareholder capital and create value with it.
The Motley Fool August 12, 2010 David Meier	Would Jeremy Grantham Buy Travelzoo? I have to believe Grantham would certainly give Travelzoo a good, hard look. And you and I should, too.
The Motley Fool August 12, 2010 David Meier	Would Jeremy Grantham Buy Tractor Supply Company? The seasoned pro thinks high-quality companies are on sale. Let's find the bargains.
The Motley Fool August 12, 2010 David Meier	Would Jeremy Grantham Buy Vascular Solutions? With quality numbers, I have to believe Grantham would certainly give it a good, hard look.
The Motley Fool August 12, 2010 David Meier	Would Jeremy Grantham Buy T. Rowe Price? The company earns a return on invested capital that is higher than its cost of capital. Fools love companies that take shareholder capital and create value with it.
The Motley Fool July 28, 2010 Matthew Argersinger	7 High-Quality Stocks for 7 Lean Years Worried about the future? Here are seven stocks that should outperform big time.
The Motley Fool August 18, 2010 David Meier	Alcon: Deflation Fighter Alcon could be a good candidate to keep you ahead of the game.
The Motley Fool October 11, 2011 Andrew Tonner	Opportunity Lying in Plain Sight Taking a page from one of the best investors out there helps us find stocks worth examining. Take a look at this list.
The Motley Fool October 27, 2009 Brian Orelli	Pfizer's and Merck's Loss Is These Companies' Gain Are Pfizer and Merck too busy integrating now to take advantage of additional acquisitions?
The Motley Fool February 10, 2010 Matt Koppenheffer	Forget the Bears: There Are Still Stocks You Should Be Buying Here's how you can find great opportunities in the stock market right now.
The Motley Fool July 28, 2004 Bill Mann	Grantham: Prepare for Pain The highly successful long-term investor and principal for investment management firm Grantham, Mayo & Van Otterloo warns of impending peril in the U.S. markets.
The Motley Fool February 11, 2005 Stephen D. Simpson	For Alcon, the Eye Is the Prize Well-balanced growth continues to be the key to this ophthalmology giant.
The Motley Fool April 8, 2008 Brian Lawler	Novartis Sees More Growth Ahead Novartis makes one of the largest acquisitions in health-care history.
BusinessWeek August 13, 2007	Life In A Time Of Bubbles Money manager Jeremy Grantham says overpriced assets are everywhere. He's prepared for a global reckoning.
The Motley Fool March 18, 2009 Brian Orelli	Merck Pummels Pfizer One of these acquisitions is not like the other.
The Motley Fool July 25, 2006 Stephen D. Simpson	An Eye-Opening Quarter at Alcon Good news may have been overdue from the eye-care company, but the jubilation seems overdone. Investors, take note.
The Motley Fool August 24, 2010 David Meier	Could Alcon Be a Multibagger? Strong returns on equity can generate powerful shareholder returns.
The Motley Fool January 27, 2010 Amanda B. Kish	Is a New Bubble Forming? At least one prominent guru is back to predicting doom and gloom, in the shape of yet another asset bubble forming right this very moment.
The Motley Fool August 5, 2010 Seth Jayson	Show Me the Money, Alcon With questionable cash sources comprising 4% of the cash flow from operations for Alcon, I am pretty confident things are OK.
The Motley Fool August 16, 2010 Alex Dumortier	Why Does the Market Hate Blue Chips? Blue-chip stocks are cheap, but why?
The Motley Fool August 30, 2010 Jim Royal	Is Microsoft Doing Right By Investors? Discover one of the Oracle of Omaha's favorite ways to size up a stock. He calculates return on invested capital to help determine whether a company has an economic moat
BusinessWeek January 6, 2011 Charles Stein	Sticking with Large-Cap Stocks for 2011 Three noted money managers are holding to their view that high-quality, large-cap stocks offer the best values in the market.
The Motley Fool January 4, 2010 Brian Orelli	You Don't Need Your Contacts In to See This Deal Novartis acts first to grab the rest of Nestle's stake in Alcon.
Registered Rep. July 12, 2011 Stan Luxenberg	Some High-Profile Mutual Fund Managers Are on a Buyer's Strike At a time when the markets are plagued by sluggish economic growth and unnerving debt burdens, some prominent funds are avoiding major categories of stocks or bonds.
Real Estate Portfolio Mar/Apr 2004 Christopher M. Wright	Q&A with Jeremy Grantham Real Estate Portfolio recently asked celebrated investment manager and noted bear Jeremy Grantham, chairman of Grantham, Mayo, Van Otterloo & Co. LLC, to share his thoughts on the capital markets and REIT stocks.
BusinessWeek May 13, 2010	Beware a Bernanke-Fueled Market Bubble Jeremy Grantham sees just a small chance of a strong recovery -- but finds high-quality stocks cheap
The Motley Fool October 20, 2005 Stephen D. Simpson	Wide Eyes at Alcon Excellent margin performance fueled exceptional growth for this eye-care titan. This is a strong and valuable cash-producing franchise, and it deserves a premium valuation -- but how much of a premium?
The Motley Fool December 30, 2005	Foolish Fundamentals: Return on Invested Capital Investors, learn to measure how much value a company creates.
The Motley Fool May 1, 2006 Stephen D. Simpson	Alcon Still Not Living Up to Valuation Though this is a very solid medical technology company, its valuation still looks too high.
Registered Rep. August 29, 2012 David Geracioti	Editor's Letter: A Contrarian Changes His Mind Malthus predicted death from starvation because of a want of food. Farms are fewer, but food is abundant. To me, there is no such thing as a limited resource. As one money manager told me, the time to invest is when you won't want to.
Financial Advisor August 2004 Evan Simonoff	Bear Brawl Comes Up Short FPA Capital's Robert Rodriguez and Grantham Mayo's Jeremy Grantham faced off to argue with a bond fund maven, Citigroup's Joe Deane, who was much more bullish on stocks than on his own asset class. The exchange took place at Morningstar's annual mutual fund conference.
The Motley Fool October 23, 2009 Brian Orelli	Swine Flu Doesn't Need to Save Novartis The company is looking healthy all on its own.
The Motley Fool August 10, 2010 David Meier	Is Apple Growing Foolishly? There's a right way and a wrong way for businesses to grow.
The Motley Fool August 30, 2010 Jim Royal	Does Wal-Mart Pass Buffett's Test? Discover one of the Oracle of Omaha's favorite ways to size up a stock.
The Motley Fool July 9, 2009 Selena Maranjian	This Metric Can Lead You to Winners Of all the measures you can use to search for quality companies, the metric known as return on invested capital can be one of the trickiest. But it's one way to find great businesses.
The Motley Fool August 3, 2010 Seth Jayson	Show Me the Money, Novartis Novartis turned 25% of its revenues into free cash flow. But, it always pays to compare that figure to sector and industry peers and competitors, to see how your company stacks up.
The Motley Fool June 16, 2010 Nate Weisshaar	You Wasted the Past 10 Years of Your Life If you're interested in preventing your investment portfolio from languishing for another decade here's how to avoid wasting the next 10.
The Motley Fool January 20, 2010 Brian Orelli	Those Are Fighting Words Alcon's minority shareholders fight back.
The Motley Fool February 28, 2007 David Meier	Higher Returns, Lower Risk Two great investors help us find the best investment opportunities today. SK Telecom... Tuesday Morning... Bank of America... Wells Fargo... Home Depot... etc.
The Motley Fool August 25, 2011 Jim Royal	Does Crox Earn Its Keep? Crocs' returns on invested capital have fluctuated over the past five years, and are currently lower than they were five years ago.
The Motley Fool September 1, 2010 Jim Royal	Is Schlumberger Doing Right By Investors? Discover one of the Oracle of Omaha's favorite ways to size up a stock, using Schlumberger as an example.
The Motley Fool August 23, 2010 James Early	Is Frontier Worth Its Salt? How does this company look on this critical metric?
The Motley Fool August 25, 2011 Jim Royal	Does Western Refining Earn Its Keep? Western Refining has improved its returns on invested capital dramatically from three years ago, but they are down from five years ago.
Financial Planning October 1, 2005 Joseph H. Ellis	Choppy Markets Ahead? A look at interest rates, consumer spending and the stock market and how charting them is a significant aid in understanding major stock-market trends for investors and financial advisers alike.
The Motley Fool March 9, 2009 Brian Orelli	Merck-Schering Trumps Pfizer-Wyeth The new Merck deal looks a lot better than a combined Pfizer plus Wyeth.
The Motley Fool August 17, 2007 David Meier	The Magic of ROIC It's amazing what ROIC, return on invested capital, can do for your ability to value a company. Although no one metric should be used exclusively, ROIC is as close to perfect as you may be able to get. Here's why.